Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caryl E Sortwell

Showing results (71-80 of 80) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 80 results.
Neurobiology of Disease|July 17, 2017
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric formTimothy J Collier, Kinshuk R Srivastava, Craig Justman, et al.
Neurobiology of Disease|June 21, 2015
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degenerationKatrina L Paumier, Kelvin C Luk, Fredric P Manfredsson, et al.
Neurobiology of Disease|July 6, 2019
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJoseph R Patterson, Megan F Duffy, Christopher J Kemp, et al.
NPJ Parkinson'S Disease|May 24, 2022
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJoseph R Patterson, Warren D Hirst, Jacob W Howe, et al.
Journal of Neuroinflammation|May 3, 2018
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degenerationMegan F Duffy, Timothy J Collier, Joseph R Patterson, et al.
Journal of Neuroinflammation|May 31, 2018
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degenerationMegan F Duffy, Timothy J Collier, Joseph R Patterson, et al.
Frontiers in Neuroscience|April 16, 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor functionSheila M Fleming, Sophia Scott, Edward J Hamad, et al.
NPJ Parkinson'S Disease|January 3, 2024
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R Patterson, Joseph Kochmanski, Anna C Stoll, et al.
JCI Insight|March 8, 2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's diseaseTracy A Cole, Hien Zhao, Timothy J Collier, et al.
Journal of Visualized Experiments : Jove|July 11, 2022
Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample PoolingJoseph R Patterson, Allyson Cole-Strauss, Nathan Kuhn, et al.
Pageof 8

Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Neurobiology of Disease|July 17, 2017
Nortriptyline inhibits aggregation and neurotoxicity of alpha-synuclein by enhancing reconfiguration of the monomeric formTimothy J Collier, Kinshuk R Srivastava, Craig Justman, et al.
Neurobiology of Disease|June 21, 2015
Intrastriatal injection of pre-formed mouse α-synuclein fibrils into rats triggers α-synuclein pathology and bilateral nigrostriatal degenerationKatrina L Paumier, Kelvin C Luk, Fredric P Manfredsson, et al.
Neurobiology of Disease|July 6, 2019
Time course and magnitude of alpha-synuclein inclusion formation and nigrostriatal degeneration in the rat model of synucleinopathy triggered by intrastriatal α-synuclein preformed fibrilsJoseph R Patterson, Megan F Duffy, Christopher J Kemp, et al.
NPJ Parkinson'S Disease|May 24, 2022
Beta2-adrenoreceptor agonist clenbuterol produces transient decreases in alpha-synuclein mRNA but no long-term reduction in proteinJoseph R Patterson, Warren D Hirst, Jacob W Howe, et al.
Journal of Neuroinflammation|May 3, 2018
Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degenerationMegan F Duffy, Timothy J Collier, Joseph R Patterson, et al.
Journal of Neuroinflammation|May 31, 2018
Correction to: Lewy body-like alpha-synuclein inclusions trigger reactive microgliosis prior to nigral degenerationMegan F Duffy, Timothy J Collier, Joseph R Patterson, et al.
Frontiers in Neuroscience|April 16, 2025
Intrastriatal injection of alpha-synuclein preformed fibrils to rats results in L-DOPA reversible sensorimotor impairments and alterations in non-motor functionSheila M Fleming, Sophia Scott, Edward J Hamad, et al.
NPJ Parkinson'S Disease|January 3, 2024
Transcriptomic profiling of early synucleinopathy in rats induced with preformed fibrilsJoseph R Patterson, Joseph Kochmanski, Anna C Stoll, et al.
JCI Insight|March 8, 2021
α-Synuclein antisense oligonucleotides as a disease-modifying therapy for Parkinson's diseaseTracy A Cole, Hien Zhao, Timothy J Collier, et al.
Journal of Visualized Experiments : Jove|July 11, 2022
Large-Scale SARS-CoV-2 Testing Utilizing Saliva and Transposition Sample PoolingJoseph R Patterson, Allyson Cole-Strauss, Nathan Kuhn, et al.
Pageof 8